Study: Factors that affect the ability to work in people with metastatic cancer Some patients who live with metastatic cancer either want or need to continue working while coping with symptoms of their disease and treatment. A recent study that looked at over 600 people with metastatic breast, prostate, colon, or lung cancer found that
Update: FDA approves new treatment for metastatic triple-negative breast cancer The FDA approved the use of sacituzumab govitecan-hizy (Trodelvy), a treatment drug for people with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. (4/27/20) Read the article Printer Friendly Page This article is most relevant for: People with
Topic: COVID-19 and Cancer The current COVID-19 pandemic has led to many changes in our communities. In this XRAY review we focus on the intersection between COVID-19 and cancer: who may be immunosuppressed, coping with changes in surveillance or treatment, and evaluating and dealing with media. (4/13/20) Este artículo está disponible en español. Printer Friendly
In 2014, one year after its formation, the Metastatic Breast Cancer Alliance (MBC Alliance) published Changing the Landscape for People Living with Metastatic Breast Cancer. Chapter 5 of the analysis showed a lack of data about the population of metastatic breast cancer (MBC) patients living across the US. The MBC Alliance identified key questions to
‘If I don’t find something that works, I will die’ Women living with metastatic breast cancer often feel isolated and invisible in the larger breast cancer narrative.
